| Objective:To investigate the clinical efficacy of LiangXueJianPi powder in the treatment of simplex anaphylactoid purpura, and to evaluate the security and recurrence rate of LiangXueJianPi powder.Method:55cases, recurrence simplex anaphylactoid purpura patients divides into two groups according to the stochastic tables law, in which experimental group30examples, the control group25examples.30patients of test group were treated by LiangXueJianPi powder,25patients of control group were treated by the western medicine convention (Chlorpheniramine tablets, Vitamin C tablets, part acetate menadiol, rutin tablets).14days for a course of medication, after two treatment courses of effects were observed, around records two groups to treat the clinical symptom, and were followed for half-year of the patients to evaluate recurrence rate.Rusults:1. Comparison of efficacy:the treatment group cured in18cases, improved in10cases, ineffective in2cases, total efficiency rate93.33%; The control group healed in8cases, improved in9cases, ineffective in8cases, total efficiency rate68.00%. The treatment group were more efficient than control group significantly. Comparing the efficiency of two groups by the x2test,P<0.05, statistically significant differences in the treatment group than in the control group.2. The incidence of adverse reactions:the treatment group occurred in1case, the incidence of adverse events was3.33%; the control group occurred in2cases, the rate of reverse reaction of8.00%. Comparing the two groups by the x2test (P>0.05),the difference was not statistically significant.3. Recurrence rate:healing patients for treatment and control groups at six months follow-up after treatment is completed, treatment group,18cases of recurrence in2cases, recurrence rates5.56%, The control group of25cases,4cases of recurrence, recurrence rate20.00%.In both groups, recovery rates (P>0.05), the difference was not statistically significant.Conclusion:The clinical research indicated the LiangXueJianPi powder treatment of the simplex anaphylactoid purpura, Curative effect to be remarkable, also Safety and low recurrence rates. |